Cite

HARVARD Citation

    Coltin, H. et al. (2022). Selumetinib for symptomatic, inoperable plexiform neurofibromas in children with neurofibromatosis type 1: A national real‐world case series. Pediatric blood & cancer. 69 (8), p. n/a. [Online]. 
  
Back to record